Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of I50L substitution in virologic failure on atazanavir-containing HAART
2004-002880-26Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atazanavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Bristol Myers Squibb. Started Sep 2005; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-002880-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002880-26.